News & Events

In this section

Cyto Study Manager Selected by Roche to Harmonize Genetic Toxicology Assay Processes

Instem Software Chosen by Roche to Integrate Data Acquisition, Reporting & Management Processes for Genetic Toxicology Investigations

CONSHOHOCKEN, PA - (BUSINESS WIRE) – September 30, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Roche has selected their recently launched Cyto Study Manager™ software system to support their genetic toxicology research program.

Developed by Perceptive Instruments, which is now operating as part of Instem, Cyto Study Manager integrates data acquisition, auditing, reporting and study management processes into a single intuitive system that greatly improves efficiencies while ensuring data integrity during genetic toxicology investigations.

“Following the recent launch of the Cyto Study Manager solution, it is exciting to see strong demand from leaders such as Roche,” comments Gary Mitchell, VP Global Marketing at Instem. “Roche has been a long time user of Instem technologies such as our Provantis® preclinical software suite, and it is encouraging to get their vote of confidence once again as they continue to streamline processes and harmonize systems.”

Cyto Study Manager  enables clients to combine comet and micronucleus data management processes within an easy-to-use system. Fully integrated with the software, researchers can now transfer data directly from automated slide scoring platforms, allowing them to seamlessly produce consolidated study reports.

Key Facts

  • Roche purchases Cyto Study Manager Software system for genetic toxicology laboratories in Basel, Switzerland
  • Long-standing client Roche expands use of Instem technologies with purchase of Cyto Study Manager system
  • Cyto Study Manager provides Roche GLP and FDA 21 CFR part 11 compliance for electronic signatures, comprehensive auditing, archiving and historical control features

Perceptive Instruments (Perceptive), now operating as part of Instem, develops, manufactures and supplies image analysis and data processing solutions that are primarily focused on the areas of genetic toxicology, microbiology and immunology. Perceptive solutions are deployed in over 50 countries at leading universities and research institutes and are supporting various government programs such as those at the National Center for Toxicological Research, a Food & Drug Administration division. Perceptive products also serve small and medium-sized companies along with many of today’s multinational organizations, including many of the leading global pharmaceutical companies.

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600